Crisan, Dana

Grigorescu, Mircea

Grigorescu, Mircea Dan

Lupsor, Monica

Radu, Corina

Sparchez, Zeno

Hepatitis Monthly

English

PubMed

Dana Crisan

Corina Radu

Monica Lupsor

Zeno Sparchez

Mircea Dan Grigorescu

Mircea Grigorescu

Crossref

Two or More Synchronous Combination of Noninvasive Tests to Increase Accuracy of Liver Fibrosis Assessement in Chronic Hepatitis C; Results From a Cohort of 446 Patients

A new combination of blood test and ﬁbroscan for accurate non-invasive diagnosis of liver ﬁbrosis stages in chronic hepatitis C.

A novel panel of blood markers to assess the degree of liver ﬁbrosis.

A simple noninvasive index can predict both signiﬁcant ﬁbrosis and cirrhosis in patients with chronic hepatitis

An evaluation of the potential cost-eﬀectiveness of non-invasive testing strategies in the diagnosis of signiﬁcant liver ﬁbrosis.

Biochemical markers of liver ﬁbrosis in patients with hepatitis C virus infection: a prospective study.

Comparative study of non-invasive methods for ﬁbrosis assessment in chronic HCV. Hepat Mon.

Comparison of eight diagnostic algorithms for liver ﬁbrosis in hepatitis C: new algorithms are more precise and entirely noninvasive.

Comparison of nine blood tests and transient elastography for liver ﬁbrosis in chronic hepatitis C: the ANRS HCEP-23 study.

Comparison of test performance proﬁle for blood tests of liver ﬁbrosis in chronic hepatitis C.

Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies.

Crisan D et al. Combination of Tests for Fibrosis Assessment

Diagnostic accuracy, reproducibility and robustness of ﬁ-brosis blood tests in chronic hepatitis C: a meta-analysis with individual data. Clin Biochem.

FIB-4: an inexpensive and accurate marker of ﬁbrosis in HCV infection. comparison with liver biopsy and ﬁbrotest.

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis [Hepatology 1981;1:431-435].

Hepascore: an accurate validated predictor of liver ﬁbrosis in chronic hepatitis C infection. Clin Chem.

Identiﬁcation of chronic hepatitis C patients without hepatic ﬁbrosis by a simple predictive model.

Independent prospective multicenter validation of biochemical markers (ﬁbrotest-actitest) for the prediction of liver ﬁbrosis and activity in patients with chronic hepatitis C: the ﬁbropaca study.

interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group.

Liver biopsy: the best, not the gold standard.

Meta-analyses of FibroTest diagnostic value in chronic liver disease.

Noninvasive prediction of ﬁbrosis in patients with chronic hepatitis C. Hepatology. 2003;37(5):1220-1; author reply 1.

Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related ﬁbrosis: an updated metaanalysis.

Prospective comparison of six non-invasive scores for the diagnosis of liver ﬁbrosis in chronic hepatitis

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of ﬁbrosis in chronic hepatitis

Prospective comparison of two algorithms combining non-invasive methods for staging liver ﬁbrosis in chronic hepatitis

SAFE biopsy: a validated method for large-scale staging of liver ﬁbrosis in chronic hepatitis

Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection.

Sampling variability of liver biopsy in nonalcoholic fatty liver disease.

Serum markers detect the presence of liver ﬁbrosis: a cohort study.

Standardization of ROC curve areas for diagnostic evaluation of liver ﬁbrosis markers based on prevalences of ﬁbrosis stages.

Stepwise combination algorithms of non-invasive markers to diagnose signiﬁcant ﬁbrosis in chronic hepatitis

The combination of a blood test and Fibroscan improves the non-invasive diagnosis of liver ﬁbrosis.

The NAFLD ﬁbrosis score: a noninvasive system that identiﬁes liver ﬁbrosis in patients with NAFLD.

The predictive value of Fibrotest vs. APRI for the diagnosis of ﬁbrosis in chronic hepatitis C. Hepatology. 2004;39(3):862-3; author reply 3.

Transient elastography: a new noninvasive method for assessment of hepatic ﬁbrosis.

Validation and comparison of indexes for ﬁbrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classiﬁcation without liver biopsies.

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3339417

Two or More Synchronous Combination of Noninvasive Tests to Increase Accuracy of Liver Fibrosis Assessement in Chronic Hepatitis C; Results From a Cohort of 446 Patients

Abstract

Similar works

Full text

Available Versions

Crossref